Targeting the brain 5-HT7 receptor to prevent hypomyelination in a rodent model of perinatal white matter injuries.

"Declarations Conflict of interestNot applicable. Ethical approval and consent to participateAll animals were handled according to the institutional guidelines of the Institut National de la Santé et de la Recherche Scientifique (Inserm, France). All protocols were approved by the ethical committee of Paris Nord and the Ministry of research (APAFIS#18422-2019010820435001). Consent for publicationAll authors consent for publication. Conflict of interest Not applicable."

"Funding This study was supported by grants from Inserm, the Université de Paris, the Horizon 2020 Framework Program of the European Union (grant agreement no. 874721/PREMSTEM), ERANET-NEURON (TRAINS), the Fondation de France, the Fondation pour la Recherche Médicale, the Fondation Grace de Monaco, the Fondation des Gueules Cassées, the Fondation Roger de Spoelberch, and additional grants from “Investissement d'Avenir -ANR-11-INBS-0011-” NeurATRIS and “Investissement d’Avenir -ANR-10-INBS-09”. The authors acknowledge financial support from a PhD fellowship from the Université de Paris (Ecole Doctorale BioSPC to CB), EUR G.E.N.E. (reference #ANR-17-EURE-0013), and is part of the Université de Paris IdEx #ANR-18-IDEX-0001 funded by the French Government through its “Investments for the Future” program. Work in P.M. lab was funded by FEBS Excellence Award 2021 (Federation of European Biochemical Societies) and the Portuguese Foundation for Science and Technology (FCT) (project PTDC/MED-NEU/28073/2017; POCI-01-0145-FEDER-028073). C.B.’s mobility to the P.M. lab was supported by the Autism and NDD GIS (GIS Autisme et Troubles du Neuro-Développement). The supporting bodies played no role in any aspect of the study design, analysis, interpretation, or decision to publish this data."